Residual Solvents: What Is Left Over From Synthesis
Solid-phase peptide synthesis uses a sequence of solvents and reagents that the final product must be separated from. How complete that separation is, and how it is verified, is not answered by an HPLC chromatogram.
Residual solvents are organic chemicals that remain in a finished peptide sample after synthesis and purification. They are not impurities in the peptide sequence sense. They are not truncated chains or deletion products. They are the chemical tools used to build and isolate the peptide, and their presence in the final powder is a question of how completely the manufacturing process removed them. A standard certificate of analysis does not answer that question. It answers a different one.
Where Solvents Enter the Process
Solid-phase peptide synthesis is a multi-stage chemical process and each stage introduces at least one solvent or reactive reagent. Understanding which solvents are present, and in what role, is the starting point for understanding what might persist.
The synthesis itself takes place on a solid resin support. For the most widely used approach, Fmoc chemistry, the resin must first be swollen in a suitable solvent. Dichloromethane (DCM) is commonly used for this. Coupling reactions, in which amino acids are attached one by one to the growing chain, use DMF (dimethylformamide) or NMP (N-methylpyrrolidone) as the main reaction solvent. Between couplings, the Fmoc protecting group on the terminal amine is removed with piperidine, typically as a 20% solution in DMF.
At the end of synthesis, the completed peptide chain must be released from the resin and all remaining side-chain protecting groups must be removed. This is done with a cleavage cocktail based on trifluoroacetic acid (TFA), which is usually present at 90 to 95% by volume. The remainder of the cocktail consists of scavengers, compounds added to intercept the reactive carbocations and other species generated during deprotection. Triisopropylsilane (TIS or TIPS) and water are the most common scavengers in a standard cocktail. Peptides containing cysteine, methionine, or tryptophan often require additional thiol-based scavengers such as ethanedithiol (EDT). After cleavage, the peptide is precipitated, typically by addition of cold diethyl ether.
Purification by reversed-phase HPLC introduces acetonitrile as the primary organic modifier in the mobile phase. The collected fractions therefore contain acetonitrile and water, along with a small concentration of TFA used as an ion-pairing reagent in the mobile phase. This is a second route by which TFA enters the product, distinct from its role as a cleavage agent.
The purified fractions are then lyophilised, meaning the solvent is removed by freeze-drying under vacuum. Lyophilisation removes most of the water and, depending on process conditions, much of the acetonitrile. It does not remove all trace solvents, and compounds that interact strongly with the peptide matrix may persist. TFA in its counterion form is notably resistant to removal by lyophilisation alone.
TFA as a Counterion, Not Just a Reagent
TFA occupies a category of its own in residual solvent discussions because it does not simply survive as a trapped volatile. After HPLC purification, basic residues in the peptide sequence, such as lysine, arginine, and the N-terminus, carry a positive charge at typical solution pH. Trifluoroacetate anions from the mobile phase bind to these sites as counterions. The peptide is then isolated as a TFA salt. The TFA is part of the material's ionic structure, not an incidental contaminant.
The practical consequence is that lyophilisation, which works well for volatile organic solvents, does not efficiently remove TFA in this form. Measured TFA content in synthetic peptides is frequently between 10 and 20% by mass of the material, meaning a sample reported as 95% pure by HPLC may contain substantial TFA by weight. The purity figure and the TFA content describe different things. See the note on how purity is defined in the companion article on peptide impurities.
Removing TFA requires either ion-exchange treatment or repeated lyophilisation from dilute acetic acid or hydrochloric acid solutions to displace the trifluoroacetate with a different counterion. Whether that step has been performed is not visible from an HPLC trace.
How Residual Solvents Are Measured
The standard method for volatile organic solvents is static headspace gas chromatography, most often with flame ionisation detection (HS-GC-FID). A weighed quantity of sample is dissolved or placed directly into a sealed headspace vial. The vial is heated to a defined temperature, allowing volatile compounds to partition into the gas above the sample. A fixed volume of that headspace gas is then injected onto a GC column, where the analytes are separated and detected. The United States Pharmacopeia includes a general chapter on residual solvents that specifies headspace GC as the reference technique.
GC-FID detects carbon-containing compounds through combustion in a hydrogen flame. It is well suited to solvents such as DMF, NMP, acetonitrile, DCM, methanol, piperidine, and diethyl ether. When identification of unknown peaks is required, or when a mass-confirmation step is needed, the detector may be replaced with or supplemented by a mass spectrometer, giving GC-MS. The combined HS-GC-FID/MS configuration is used in some laboratories for simultaneous screening and identification.
TFA is a different case. Because it exists primarily as a non-volatile counterion in peptide samples, headspace GC gives an incomplete picture of total TFA content. Two alternative approaches are more appropriate. Ion chromatography separates anions in aqueous solution using an ion-exchange column and suppressed conductivity detection. The trifluoroacetate anion is quantified directly by this technique. Fluorine-19 NMR (19F NMR) is a second option. Because most peptides contain no fluorine, the signal from the trifluoromethyl group of TFA appears without interference from the peptide matrix. Both methods have been validated and published for TFA quantification in synthetic peptide materials.
Water content is a related but separate measurement, addressed by Karl Fischer titration rather than GC. That method is covered in detail in the article on water content and Karl Fischer titration.
The Regulatory Framework
ICH Q3C is an international harmonisation guideline on residual solvents in pharmaceutical products. It classifies solvents by their toxicological risk profile into three classes. Class 1 solvents are those that should be avoided in pharmaceutical manufacturing because of known or strongly suspected human toxicity or unacceptable environmental hazard. Class 2 solvents are those that should be limited because they carry inherent but manageable toxicity, including potential carcinogenicity or organ toxicity in animals. Class 3 solvents have low toxic potential and are considered to present less risk at levels typically found after reasonable manufacturing practices.
ICH Q3C sets permitted daily exposure (PDE) limits for each solvent, expressed as the maximum acceptable intake per day from a pharmaceutical product. DMF and NMP, two of the principal coupling solvents in SPPS, appear in Class 2. Both have been subject to additional scrutiny in Europe under REACH chemical regulation because of concerns about reproductive toxicity. Acetonitrile is classified as Class 2. DCM appears in Class 2. Piperidine is Class 3. TFA is not listed in ICH Q3C in the same way as a typical process solvent, partly because its presence as a counterion rather than a freely volatile residue places it in a different analytical and regulatory context.
ICH Q3C describes requirements for pharmaceutical drug products intended for human use. Research-use peptides are not pharmaceutical drug products and are not formally subject to this framework. The classification is nonetheless a useful reference when evaluating what levels of a given solvent might be of concern.
Why It Rarely Appears on a Basic Certificate
A standard research-grade certificate of analysis typically includes an HPLC purity figure, a mass spectrometry identity confirmation, and sometimes a water content result. Those three measurements address the most common questions: is this the right peptide and how much of the material is that peptide.
Residual solvent testing is not included in that standard set for practical reasons. Headspace GC is a separate instrument run with its own sample preparation, calibration standards, and method validation requirements. Ion chromatography or 19F NMR for TFA is a further separate assay. Each consumes sample material. Each adds time and cost to the analysis. Unless a customer specifically requests residual solvent data, the laboratory does not perform the assays and therefore has nothing to report.
The absence of a residual solvent line on a certificate means the measurement was not performed. It carries no information about whether solvents are present or at what level. A certificate that is silent on residual solvents is not a certificate that confirms their absence. This distinction matters for anyone drawing conclusions about sample composition from the document alone.
As a practical illustration: a sample showing 98% purity by HPLC at 220 nm may also contain several percent TFA by mass, some residual DMF, and measurable acetonitrile. None of those would register as a peak in the HPLC purity integration. The certificate accurately reports the purity it measured. It does not report what it did not measure.
Requesting Residual Solvent Testing
When residual solvent data is required, a separate assay panel must be ordered. The scope of that panel should be defined by the solvents that are plausible given the synthetic route. For a standard Fmoc SPPS product purified by RP-HPLC, the candidates are DMF, NMP, acetonitrile, DCM, piperidine, and TFA. Diethyl ether and methanol may be relevant depending on precipitation and washing procedures.
The report should state the method used, the limit of detection or limit of quantitation for each analyte, and the result expressed as a concentration or as "not detected" with the threshold clearly specified. A result of "not detected" without a stated detection limit is not fully informative, because the same phrase applies whether the method was sensitive to 10 ppm or 500 ppm. The same principle applies to all analytical results: the measurement's limits define the meaning of its output. This is discussed in the context of HPLC results in the article on reading a peptide COA.
TFA testing requires a specific request because, as described above, the analytical approach differs from the headspace GC used for other solvents. If TFA content is relevant to the intended use of the material, it should be explicitly included in the testing scope rather than assumed to be covered by a general residual solvents panel.
What a Certificate Describes
A certificate of analysis describes the sample submitted to the laboratory at the time of analysis. It records what was measured, by which method, and what result was obtained. It does not describe what was not measured. It does not make claims about safety or suitability for any particular application. Purity is a measure of composition, not a statement about the absence of all possible contaminants.
Novagen Analytical Laboratories is a third-party analytical laboratory. It reports what was found in the sample provided. Its certificate register is publicly available at novagenlaboratories.com/verify, where reports can be confirmed against their unique lot identifiers. Residual solvent testing, including TFA quantification by ion chromatography, can be included in a testing scope on request. Current turnaround is 21 days from receipt of samples. Enquiries can be directed to admin@novagenlaboratories.com.
The question a residual solvents test answers is specific: how much of a named solvent is present in this sample, by this method, above this detection threshold. That answer requires the test to be performed. A certificate that does not include the result did not include the test.
Common questions
- What residual solvents are most commonly found in synthetic peptides?
The solvents most likely to persist depend on where in synthesis they are used. DMF and NMP are the main coupling solvents and can adsorb onto the dried product. Acetonitrile is the dominant HPLC purification solvent and is introduced late in the process. TFA is present both as the cleavage reagent and as a counterion on basic residues after purification. Piperidine, used for Fmoc deprotection, and DCM, used for resin swelling and washing, are also candidates, though both are more volatile and are largely removed during workup and lyophilisation.
- Why is TFA not measured by standard headspace GC like other residual solvents?
Headspace gas chromatography relies on volatile analytes partitioning into the gas phase above a heated sample. TFA has some volatility, but in peptide samples it predominantly exists as a trifluoroacetate counterion bound to protonated basic amino acid residues. In that ionic form it does not behave like a simple volatile solvent in a headspace experiment. Ion chromatography, which separates anions in solution, and 19F NMR, which detects the fluorine nucleus selectively, are better suited to quantifying TFA in its counterion form. Both approaches have been validated in the published literature for this purpose.
- What is ICH Q3C and does it apply to research peptides?
ICH Q3C is an international harmonisation guideline on residual solvents in pharmaceutical drug products. It classifies solvents into three classes based on their toxicological profiles: Class 1 solvents should be avoided because of unacceptable toxicity or environmental hazard; Class 2 solvents should be limited because of their inherent toxicity; and Class 3 solvents have low toxic potential. The guideline sets permitted daily exposure limits for each class. ICH Q3C applies within pharmaceutical manufacturing and regulatory submissions. Research-use-only peptide materials are not pharmaceutical drug products and are not formally regulated under it. However, the classification framework is still a useful reference for understanding why certain solvent levels matter.
- Can residual solvents affect a peptide purity result?
They can contribute to mass but not to UV absorbance at 220 nm, which is the wavelength typically used for HPLC purity integration. A sample with significant residual solvent content may show a high HPLC purity figure because the solvent does not register as a peptide peak. The reported purity reflects the peptide composition of the sample as it absorbs at that wavelength, not the total composition of the material. Residual solvents and water content are independent measurements that provide a more complete picture of what the powder actually is.
- How is residual solvent testing done and how much sample does it require?
For most volatile solvents the standard approach is static headspace gas chromatography with flame ionisation detection, often abbreviated HS-GC-FID. A sealed vial containing the dissolved or directly weighed sample is heated to allow volatile compounds to equilibrate into the headspace gas, which is then injected onto a GC column. The method requires a separate sample preparation and instrument run from the HPLC purity assay. For TFA specifically, ion chromatography or 19F NMR requires its own sample aliquot. Because each assay consumes sample and instrument time, residual solvent testing is ordered separately from a standard purity and identity report rather than being included by default.
- What does "not detected" mean in a residual solvents result?
"Not detected" means the analyte was not found above the limit of detection for that specific method, in that specific sample, on that specific instrument. It does not mean the solvent is absent. Every analytical method has a detection threshold, and anything below that threshold produces the same result as a truly clean sample. When reviewing a residual solvents report, the limit of detection or limit of quantitation should be stated alongside the result. Without those values, "not detected" carries less meaning than it appears to.